ATB Capital analyst Frederico Gomes assumed coverage of TerrAscend with an Outperform rating and C$3.50 price target. The analyst believse TerrAscend will accelerate growth and continue to improve margins in the second half of 2023, driven by the start of adult-use sales in Maryland on July 1, improvements in Michigan, and consistent performance in New Jersey.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TRSSF:
- TerrAscend (TSX: TSND) Commences Trading on the TSX
- TerrAscend Increases Footprint in Maryland to Four Dispensaries with Agreement to Acquire Herbiculture, Transaction Already Approved by Maryland Regulator
- TerrAscend Closes on Third Dispensary Acquisition in Maryland Ahead of Adult-Use Launch
- TerrAscend upgraded to Buy from Hold at Craig-Hallum
- TerrAscend announces $37M paydown of senior secured term loan